GlassScriptPhysician profile
Parvez M Fatteh
NPI 1194774075
$2,147.14
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $89.87 · 2021: $733 · 2022: $454 · 2023: $75.65 · 2024: $24.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $451.61 | 2019-2024 | |
| Biohaven Pharmaceuticals, INC. | $368.41 | 2021 | |
| Collegium Pharmaceutical, INC. | $291.24 | 2019-2022 | |
| Daiichi Sankyo INC. | $173.61 | 2019 | |
| Redhill Biopharma INC. | $154.89 | 2020-2021 | |
| Shionogi INC | $127.60 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.11 | 2019 | |
| Forte Bio-Pharma LLC | $76.62 | 2021 | |
| Boston Scientific Corporation | $72.46 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $66.92 | 2022 | |
| Arbor Pharmaceuticals, INC. | $33.04 | 2019-2021 | |
| Pfizer INC. | $30.28 | 2019 | |
| Biodelivery Sciences International, INC. | $29.84 | 2019-2020 | |
| Mdd US Operations, LLC | $28.15 | 2019 | |
| Kaleo, INC. | $26.41 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $22.28 | 2022 | |
| Amgen INC. | $20.22 | 2022 | |
| Neuronetics, INC. | $17.71 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.95 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.86 | 2022 | |
| Hikma Pharmaceuticals USA | $13.65 | 2022 | |
| Zyla Life Sciences, INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parvez Fatteh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.